WallStreetZenWallStreetZen

NASDAQ: RENE
Cartesian Growth Corp Ii Stock

$11.05+0.00 (+0%)
Updated Feb 23, 2024
RENE Price
$11.05
Fair Value Price
N/A
Market Cap
$317.69M
52 Week Low
$10.41
52 Week High
$11.92
P/E
44.2x
P/B
-17.98x
P/S
N/A
PEG
1.56x
Dividend Yield
N/A
Revenue
$0.00
Earnings
$8.73M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.01
Operating Cash Flow
-$559k
Beta
-0.03
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

RENE Overview

Cartesian Growth Corporation II focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in New York, New York.

Zen Score

Industry Average (6)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how RENE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

RENE ($11.05) is trading above its intrinsic value of $3.85, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RENE is poor value based on its earnings relative to its share price (44.2x), compared to the US market average (33.56x)
P/E vs Market Valuation
RENE is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more RENE due diligence checks available for Premium users.

Be the first to know about important RENE news, forecast changes, insider trades & much more!

RENE News

Valuation

RENE fair value

Fair Value of RENE stock based on Discounted Cash Flow (DCF)
Price
$11.05
Fair Value
$29.36
Undervalued by
62.36%
RENE ($11.05) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

RENE price to earnings (PE)

For valuing profitable companies with steady earnings
Company
44.2x
Industry
24.88x
Market
33.56x
RENE is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
RENE is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

RENE price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-17.98x
Industry
-15.59x

RENE price to earnings growth (PEG)

For valuing profitable companies with growth potential
RENE is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

RENE's financial health

Profit margin

Revenue
$0.0
Net Income
$1.9M
Profit Margin
0%
RENE's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$248.8M
Liabilities
$17.7M
Debt to equity
-1.01
RENE's short-term liabilities ($218.15k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RENE's long-term liabilities ($17.53M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RENE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
RENE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$190.7k
Investing
$0.0
Financing
$0.0
RENE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

RENE vs Shell Company Stocks

TickerMarket Cap1d %P/EP/B
RENE$317.69M0.00%44.20x-17.98x
IPXX$325.94M0.00%N/A-25.90x
IVCB$307.11M+0.23%-65.38x-9.45x
HYAC$306.70M+0.14%N/A-38.65x
JWSM$306.09M-0.82%47.57x-53.51x

Cartesian Growth Ii Stock FAQ

What is Cartesian Growth Ii's quote symbol?

(NASDAQ: RENE) Cartesian Growth Ii trades on the NASDAQ under the ticker symbol RENE. Cartesian Growth Ii stock quotes can also be displayed as NASDAQ: RENE.

If you're new to stock investing, here's how to buy Cartesian Growth Ii stock.

What is the 52 week high and low for Cartesian Growth Ii (NASDAQ: RENE)?

(NASDAQ: RENE) Cartesian Growth Ii's 52-week high was $11.92, and its 52-week low was $10.41. It is currently -7.3% from its 52-week high and 6.15% from its 52-week low.

How much is Cartesian Growth Ii stock worth today?

(NASDAQ: RENE) Cartesian Growth Ii currently has 28,749,998 outstanding shares. With Cartesian Growth Ii stock trading at $11.05 per share, the total value of Cartesian Growth Ii stock (market capitalization) is $317.69M.

Cartesian Growth Ii stock was originally listed at a price of $9.99 in May 9, 2022. If you had invested in Cartesian Growth Ii stock at $9.99, your return over the last 1 years would have been 10.61%, for an annualized return of 10.61% (not including any dividends or dividend reinvestments).

How much is Cartesian Growth Ii's stock price per share?

(NASDAQ: RENE) Cartesian Growth Ii stock price per share is $11.05 today (as of Feb 23, 2024).

What is Cartesian Growth Ii's Market Cap?

(NASDAQ: RENE) Cartesian Growth Ii's market cap is $317.69M, as of Feb 25, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cartesian Growth Ii's market cap is calculated by multiplying RENE's current stock price of $11.05 by RENE's total outstanding shares of 28,749,998.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.